RTA 408 attenuates TBHP-Induced apoptosis in nucleus pulposus cells via Nrf2/ARE and NF-κB signaling pathways: in vitro and in vivo evidence for mitigating rats’ intervertebral disc degeneration
RTA 408 mitigates oxidative stress-induced NPC apoptosis and ECM degradation via dual modulation of Nrf2/ARE activation and NF-κB suppression. Systemic administration of RTA 408 delays IDD progression in vivo, highlighting its therapeutic potential for degenerative spinal disorders. These findings support further clinical exploration of RTA 408 as a novel Nrf2-targeted therapy for IDD.
Authors
- Zengxin Jiang (ORCID: https://orcid.org/0000-0003-1474-2454)
- Jichang Fei (ORCID: https://orcid.org/0009-0002-5928-2295)
- Li‐Han Chen (ORCID: https://orcid.org/0000-0002-4789-3155)
- Mengxuan Bian
- Defang Li (ORCID: https://orcid.org/0000-0003-4151-9151)
- Weibin Chen (ORCID: https://orcid.org/0000-0001-5096-4551)
- Qingmin Zeng (ORCID: https://orcid.org/0000-0002-0775-9162)
- Jingping Wu (ORCID: https://orcid.org/0000-0001-7685-5775)
Institutions
- Fujian Medical University (CN)
- Fudan University (CN)
- Jinshan Hospital of Fudan University (CN)
- First Affiliated Hospital of Fujian Medical University (CN)
- Zhongshan Hospital (CN)
Publication Details
- Journal
- Arthritis Research & Therapy
- Published
- 2025-06-19
- DOI
- https://doi.org/10.1186/s13075-025-03588-7
- Citations
- 3
- Primary Topic
- Spine and Intervertebral Disc Pathology
- Type
- article
- Field-Weighted Citation Impact
- 4.41
Funders
- National Natural Science Foundation of China